Stay updated on Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Sign up to get notified when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.

Latest updates to the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision/version label has been updated (v3.5.2 → v3.5.3) for the ClinicalTrials.gov record history display, without changing the underlying study record information shown.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedA new revision entry v3.5.0 is added; the old revision v3.4.3 is removed from the history.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision history shows a new revision, v3.4.3, added and v3.4.2 removed.SummaryDifference0.1%

- Check84 days agoChange DetectedNew revision entry (v3.4.2) added and an older government funding notice banner removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check91 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.